BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38812673)

  • 21. Corrigendum to "Effects of a symptom management intervention based on group sessions combined with a mobile health application for persons living with HIV in China: A randomized controlled trial" [Int J Nurs Sci 8 (2021) 370-379].
    Han S; Pei Y; Zhao R; Hu Y; Zhang L; Qi X; Zhu Z; Sun W; Wu B
    Int J Nurs Sci; 2023 Oct; 10(4):603. PubMed ID: 38020830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrigendum to "Bereavement stressors and psychosocial well-being of young adults following the loss of a parent - A cross-sectional survey" [Eur. J. Oncol. Nurs. 35 (2018) 33-38].
    Lundberg T; Forinder U; Olsson M; Fürst CJ; Årestedt K; Alvariza A
    Eur J Oncol Nurs; 2019 Jun; 40():1. PubMed ID: 31229197
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of Evidence-Based Practice Programs on Individual Barriers of Workforce Nurses: An Integrative Review.
    Middlebrooks R; Carter-Templeton H; Mund AR
    J Contin Educ Nurs; 2016 Sep; 47(9):398-406. PubMed ID: 27580506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RETRACTED: The Mediating Effect of Social Capital on the Relationship Between Public Health Managers' Transformational Leadership and Public Health Nurses' Organizational Empowerment in Korea Public Health.
    Jun SY
    Asian Nurs Res (Korean Soc Nurs Sci); 2017 Dec; 11(4):246-252. PubMed ID: 29290271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum to "Adjuvant and first line chemotherapy use for endometrial cancer" [Gynecol. Oncol. Rep. 41 (2022) 101002].
    Knisely A; Huang Y; Li Y; Prabhu VS; Wright JD
    Gynecol Oncol Rep; 2023 Apr; 46():101112. PubMed ID: 37082519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrigendum to "Why should radiation oncology do translational research?" [Rep Pract Oncol Radiother 2019;24(1):60-64].
    Cañas R; Linares I; Guedea F; Berenguer Francés MÁ
    Rep Pract Oncol Radiother; 2019; 24(2):151. PubMed ID: 30723386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corrigendum to 'Development and psychometric analysis of the 10-item resilience scale specific to cancer: A multidimensional item response theory analysis' [Eur. J. Oncol. Nurs.] 41 (2019) 64-71.
    Ye ZJ; Zhang Z; Tang Y; Liang J; Sun Z; Zhang XY; Liang MZ; Yu YL
    Eur J Oncol Nurs; 2019 Oct; 42():163. PubMed ID: 31466823
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to "Two compound techniques for total body irradiation" [Tech. Innov. Patient Support Radiat. Oncol. 21 (2022) 1-7].
    Hansen AT; Rose HK; Yates ES; Hansen J; Petersen JBB
    Tech Innov Patient Support Radiat Oncol; 2023 Mar; 25():100199. PubMed ID: 36659910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corrigendum to "Co-existent abdominoperitoneal tuberculosis with endometrial cancer: A diagnostic and surgical challenge" [Gynecol. Oncol. Rep. 37 (2021) 100848].
    Ashraf M; Goh WA; Tan EMX; Nadarajah R
    Gynecol Oncol Rep; 2021 Nov; 38():100861. PubMed ID: 34977315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corrigendum to "Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation" [Gynecol. Oncol. Rep. 22 (2017) 9-12].
    Martin M; Grisham RN; Turashvili G; Halpenny DF; Aghajanian CA; Makker V
    Gynecol Oncol Rep; 2017 Nov; 22():118. PubMed ID: 29296657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corrigendum to "Metastatic hepatoid carcinoma of ovarian origin - A case report from Northern Pakistan" [Gynecol. Oncol. Rep. 21 (2017) 24-27].
    Mahmood H; Fatima H; Faheem M
    Gynecol Oncol Rep; 2017 Nov; 22():117. PubMed ID: 29296656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corrigendum to "Effects of an interactive coaching intervention on quality of life and psychological factors for colorectal cancer survivors: A single group pre and posttest design" [Eur. J. Oncol. Nurs. 66C (2023) 102413].
    Yoon J; Lee H; Son H
    Eur J Oncol Nurs; 2023 Dec; 67():102454. PubMed ID: 37968148
    [No Abstract]   [Full Text] [Related]  

  • 33. Corrigendum to "Harmonization of breast cancer radiotherapy treatment planning in the Netherlands" [Tech. Innov. Patient Support Radiat. Oncol. 19 (2021) 26-32].
    Hurkmans C; Duisters C; Peters-Verhoeven M; Boersma L; Verhoeven K; Bijker N; Crama K; Nuver T; van der Sangen M
    Tech Innov Patient Support Radiat Oncol; 2023 Mar; 25():100196. PubMed ID: 36659912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020) 100532].
    Santin AD; Filiaci V; Bellone S; O'Cearbhaill R; Ratner ES; Mathews CA; Cantuaria G; Gunderson CC; Rutledge T; Buttin BM; Lankes HA; Birrer MJ
    Gynecol Oncol Rep; 2020 Aug; 33():100590. PubMed ID: 32885014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corrigendum to "Challenges in the transition to independent radiation oncology practice and targeted interventions for improvement" [Tech. Innov. Patient Support Radiat. Oncol. 24 (2022) 113-117].
    De Leo AN; Drescher N; Bates JE; Yeung AR
    Tech Innov Patient Support Radiat Oncol; 2023 Mar; 25():100202. PubMed ID: 36873801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SIN-BARRSS - Developing a mnemonic to support nurses' participation in interprofessional ward rounds in intensive care: An appreciative inquiry for quality improvement.
    Merriman C; Freeth D
    Intensive Crit Care Nurs; 2024 Apr; 81():103609. PubMed ID: 38155052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corrigendum to "Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance" [Gynecol. Oncol. Rep. 34 (2020) 100648].
    Oh J; Barve M; Senzer N; Aaron P; Manning L; Wallraven G; Bognar E; Stanbery L; Horvath S; Manley M; Nemunaitis J; Walter A; Rocconi RP
    Gynecol Oncol Rep; 2021 May; 36():100740. PubMed ID: 34095420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].
    López Torrecilla J; Hervás A; Zapatero A; Gómez Caamaño A; Macías V; Herruzo I; Maldonado X; Gómez Iturriaga A; Casas F; González San Segundo C
    Rep Pract Oncol Radiother; 2016; 21(1):90-2. PubMed ID: 26900365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corrigendum to "Evaluation of image-guided and surface-guided radiotherapy for breast cancer patients treated in deep inspiration breath-hold: A single institution experience" [Tech. Innov. Patient Support Radiat. Oncol. 21 (2022) 51-57].
    Penninkhof J; Fremeijer K; Offereins-van Harten K; van Wanrooij C; Quint S; Kunnen B; Hoffmans-Holtzer N; Swaak A; Baaijens M; Dirkx M
    Tech Innov Patient Support Radiat Oncol; 2023 Mar; 25():100198. PubMed ID: 36654719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer.
    Katz H; Wassie E; Alsharedi M
    Med Oncol; 2017 Sep; 34(10):170. PubMed ID: 28864844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.